Blood Advances | 2024
Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.
Akhtar OS, Oloyede T, Brazauskas R, Afrough A, Hashmi H, Sidana S, Ahmed N, Bye M, Hansen DK, Ferreri CJ, Dhakal B, Dhanda DS, Harrison MJ, Kitali A, Landau HJ, Mirza A, Patel J, Patwardhan P, Qazilbash MH, Patel KK, Nishihori T, Ganguly S, Gowda L, Anderson LD, Pasquini MC, Usmani SZ, Freeman CL
PubMed
PMID: 39786391
Abstract
Related Articles
CIBMTR Study #: MM23-01b